BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17695304)

  • 1. [Superior mesenteric and portal vein thrombosis in a polycythemia vera patient with JAK2 mutation].
    Araki N; Takimoto R; Chiba H; Araki H; Sato T; Iyama S; Hirakawa M; Ono K; Kawano Y; Takada K; Miyanishi K; Kobune M; Matsunaga T; Kato J; Nakamura T; Niitsu Y
    Rinsho Ketsueki; 2007 Jul; 48(7):554-8. PubMed ID: 17695304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenteric ischemia and protein S deficiency: a rare case report.
    Llovera I; Roit Z; Kiriaki S; Sama A; Loscalzo J; Goyal N
    J Emerg Med; 2010 Nov; 39(5):579-82. PubMed ID: 18180128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of superior mesenteric and portal vein thrombosis with direct thrombolytic infusion via an operatively placed mesenteric catheter.
    Kaplan JL; Weintraub SL; Hunt JP; Gonzalez A; Lopera J; Brazzini A
    Am Surg; 2004 Jul; 70(7):600-4. PubMed ID: 15279182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenteric venous thrombosis due to antithrombin III deficiency.
    Maung R; Kelly JK; Schneider MP; Poon MC
    Arch Pathol Lab Med; 1988 Jan; 112(1):37-9. PubMed ID: 3337617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders.
    Owens CD
    J Vasc Surg; 2010 Jul; 52(1):205-7. PubMed ID: 20434300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation.
    Grandone E; Colaizzo D; Tiscia GL; Vergura P; Chinni E; Iannaccone L; Antinolfi I; Guardascione MA; Margaglione M
    Thromb Haemost; 2008 Mar; 99(3):640-2. PubMed ID: 18327418
    [No Abstract]   [Full Text] [Related]  

  • 7. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.
    Colaizzo D; Amitrano L; Tiscia GL; Scenna G; Grandone E; Guardascione MA; Brancaccio V; Margaglione M
    J Thromb Haemost; 2007 Jan; 5(1):55-61. PubMed ID: 17059429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pyoderma gangrenosum and portal vein thrombosis in a 33-year-old female patient].
    Schiefke I; Halm U; Paasch U; Pönisch W; Berr F; Mössner J
    Dtsch Med Wochenschr; 1999 Feb; 124(6):142-5. PubMed ID: 10081477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H; Spivak JL
    Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenteric venous thrombosis secondary to polycythemia vera.
    Ostermiller W; Carter R
    Am Surg; 1969 Jun; 35(6):407-9. PubMed ID: 5770207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinogen-guided thrombolysis with urokinase of a portal and mesenterial venous thrombosis during an acute episode of ulcerative colitis].
    Brueck M; Runde T; Rauber K; Kramer W
    Dtsch Med Wochenschr; 2006 Jan; 131(3):84-8. PubMed ID: 16418946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Portal vein thrombosis as the main symptom of unclassified JAK2-positive myeloproliferative neoplasm--case report].
    Karakulska-Prystupiuk E; Gierej B; Paszkowska-Kowalewska M; Wilkowojska U; Jedrzejczak WW
    Pol Merkur Lekarski; 2012 Jul; 33(193):29-31. PubMed ID: 22993907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis.
    Orr DW; Patel RK; Lea NC; Westbrook RH; O'Grady JG; Heaton ND; Pagliuca A; Mufti GJ; Heneghan MA
    Aliment Pharmacol Ther; 2010 Jun; 31(12):1330-6. PubMed ID: 20331577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Portal vein thrombosis associated with essential thrombocytosis. Clinical cases and review of the literature].
    Carvajal S; Zapata R; Bertín P; Miquel JF
    Rev Med Chil; 1996 Mar; 124(3):353-8. PubMed ID: 9008949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent deep vein thrombosis and myeloproliferative syndrom: emergence of JAK2 mutation five years after the initial event].
    Salort A; Seinturier C; Molina L; Lévèque P; Imbert B; Pernod G
    J Mal Vasc; 2014 May; 39(3):207-11. PubMed ID: 24721000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease.
    Allegra A; Alonci A; Penna G; D'Angelo A; Rizzotti P; Granata A; Musolino C
    Acta Haematol; 2009; 121(4):218-20. PubMed ID: 19478480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of cavernoma of portal vein associated with polycythemia vera].
    Kim KT; Lee SW; Han SY; Kim BH; Kang KT; Roh MH; Han JY
    Korean J Hepatol; 2006 Dec; 12(4):568-73. PubMed ID: 17237636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Segmental short bowel stenosis after a superior mesenteric vein thrombosis. Report of a case].
    Uribe S; Feres E; Flores C
    Rev Med Chil; 1999 Nov; 127(11):1369-74. PubMed ID: 10835725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic enteritis resulting from polycythemia vera.
    Yagi S; Kioka K; Koizumi Y; Nakai T; Kawasaki Y; Tsutsumi M; Ishii N; Yamasaki T; Nebiki H; Maeda K
    Clin J Gastroenterol; 2022 Oct; 15(5):907-912. PubMed ID: 35831680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation.
    P'ng S; Carnley B; Baker R; Kontorinis N; Cheng W
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):472-5. PubMed ID: 18328792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.